PBH
Prestige Consumer Healthcare Inc.
NYSE · USHealthcareMedical - Distribution
$50.41+0.98%
Price as of Jul 20, 2026
PBH growth
Prestige Consumer Healthcare Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- -4.3%
- EBITDA
- -7.9%
- EBIT
- -8.1%
- EPS
- -8.8%
- Free cash flow
- +4.5%
- Operating cash flow
- +5.5%
Forward estimates
- Revenue
- +6.0%
- EBITDA
- -7.8%
- EPS
- +22.7%
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- +247.7%
- EBIT
- -4.9%
- Net income
- -4.7%
- EPS
- -3.4%
- Free cash flow
- +4.6%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.